U
ABBV icon

UBS’s AbbVie ABBV Stock Holding History

UBS’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$2.35M Buy
40,700
+24,700
+154% +$1.37M ﹤0.01% 2760
2014
Q2 		$903K Buy
16,000
+2,500
+19% +$131K ﹤0.01% 3645
2014
Q1 		$694K Sell
13,500
-72,500
-84% -$3.66M ﹤0.01% 3894
2013
Q4 		$4.54M Sell
86,000
-17,700
-17% -$870K ﹤0.01% 1960
2013
Q3 		$4.64M Buy
103,700
+28,700
+38% +$1.27M ﹤0.01% 1773
2013
Q2 		$3.1M Buy
+75,000
New +$3.28M ﹤0.01% 2076

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UBS's ABBV Position: Q3 2014 in Review

UBS increased its AbbVie (ABBV) stake by 3% in Q3 2014, buying an estimated $5.63M and bringing the position to 3,492,813 shares worth $202M. The position accounts for 0.15% of the portfolio, ranked #151.

UBS first reported a position in ABBV in Q2 2013 and has held it in 6 quarters since. The position peaked at $228M in Q4 2013. 1,501 funds tracked by Wall St. Rank hold ABBV as of Q3 2014.

  • UBS held 3,492,813 shares of AbbVie worth $202M as of Q3 2014.
  • UBS bought 101,378 AbbVie shares in Q3 2014, an estimated $5.63M.
  • AbbVie made up 0.15% of UBS's portfolio in Q3 2014, its #151 holding.
  • UBS first reported a position in AbbVie in Q2 2013 and has held it in 6 quarters since.
  • UBS's AbbVie position peaked at $228M in Q4 2013.
  • 1,501 funds tracked by Wall St. Rank held AbbVie as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.